Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 28, 2009; 15(4): 431-440
Published online Jan 28, 2009. doi: 10.3748/wjg.15.431
Published online Jan 28, 2009. doi: 10.3748/wjg.15.431
Figure 6 DNR accumulation of HepG2/mdr1 (A, B) and HepG2 cells (C) pre- and post-transfection.
Compared with control groups, accumulation of daunorubicin in cells treated with shRNA vectors increased significantly (79.32% vs 37.96%, P < 0.05). There was no difference in sensitive cells of HepG2 between test groups (79.32% vs 87.56%).
-
Citation: Pan GD, Yang JQ, Yan LN, Chu GP, Liu Q, Xiao Y, Yuan L. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1
in vivo andin vitro . World J Gastroenterol 2009; 15(4): 431-440 - URL: https://www.wjgnet.com/1007-9327/full/v15/i4/431.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.431